Allogeneic bone marrow-derived mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Allogeneic bone marrow-derived mesenchymal stem cells, covering 2014-12-30 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines [Phase 1]